Physician
Shahen, Samir
Shahen, Samir was paid $2.09M by Medicaid between Jan 2018 and Dec 2024, across 48 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 35% of everything it billed.
33Billing provider infoSHAHEN, SAMIR
CHICAGO, IL 60622
CHICAGO, IL 60622
33aNPI1558773663assigned 05/22/2014
33bProvider typeFamily Medicine Physician
28Total paid$2.09M
24GClaims46,059
24DCodes billed48
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Illinois
Rank by total paid#42 of 2,947
Median peer was paid$43K
This provider vs. median49×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,259 | $19K | |
| 2019 | 3,445 | $58K | |
| 2020 | 3,335 | $89K | |
| 2021 | 4,324 | $207K | |
| 2022 | 10,260 | $496K | |
| 2023 | 14,034 | $678K | |
| 2024incomplete | 9,402 | $539K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 35% | 14,839 | 10,967 | $733K |
| 95144 | 11% | 685 | 110 | $225K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9.8% | 2,739 | 2,228 | $205K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 9.8% | 4,326 | 4,102 | $204K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 7.7% | 3,238 | 2,779 | $161K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 3.6% | 2,028 | 899 | $75K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 3.4% | 3,243 | 1,779 | $72K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | 3.0% | 2,880 | 985 | $63K |
| 99238 | Hospital discharge day management, 30 minutes or less | 2.0% | 1,641 | 1,434 | $42K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.0% | 1,764 | 1,608 | $41K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 1.9% | 311 | 133 | $40K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.7% | 2,442 | 2,295 | $36K |
36 more codes
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 1.6% | 351 | $33K |
| 99204 | Doctor's office visit, new patient (more involved) | 1.3% | 346 | $27K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 1.2% | 513 | $25K |
| 95923 | <1% | 222 | $16K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 169 | $14K |
| 95924 | <1% | 120 | $10K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 133 | $10K |
| 99384 | <1% | 81 | $9K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 103 | $8K |
| 93923 | <1% | 144 | $8K | |
| 95921 | <1% | 107 | $5K | |
| 99223 | Prolong inpt eval add15 m | <1% | 46 | $5K |
| 99383 | <1% | 35 | $3K | |
| 81025 | <1% | 466 | $2K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 28 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 221 | $2K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 43 | $2K |
| 81002 | <1% | 534 | $1K | |
| 96127 | <1% | 93 | $1K | |
| 99205 | Prolong outpt/office vis | <1% | 13 | $1K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 92 | $1K |
| 94761 | <1% | 56 | $820.80 | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 14 | $743.98 |
| 93040 | <1% | 88 | $640.61 | |
| 99051 | <1% | 1,088 | $268.59 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 20 | $263.79 |
| 81003 | <1% | 95 | $189.90 | |
| 81001 | <1% | 56 | $157.81 | |
| 86580 | <1% | 15 | $92.27 | |
| 94760 | <1% | 12 | $48.40 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 24 | $31.35 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 19 | $2.36 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 114 | $0.00 |
| G8730 | Pain assessment documented as positive using a standardized tool and a follow-up plan is documented | 0% | 17 | $0.00 |
| G8509 | Pain assessment documented as positive using a standardized tool, follow-up plan not documented, reason not given | 0% | 27 | $0.00 |
| G8732 | No documentation of pain assessment, reason not given | 0% | 418 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.